Angliana Chouw

Dr. Angliana Chouw

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 March 2021 in Regenerative Engineering and Translational Medicine
Verified
Journal Article
Closed access
PDF file
ACAngliana Chouw
Angliana Chouw
TMTiana Milanda
Tiana Milanda
CSCynthia Retna Sartika
Cynthia Retna Sartika
MKMarsya Nilam Kirana
Marsya Nilam Kirana
DHDanny Halim
Danny Halim
AFAhmad Faried
Ahmad Faried

1 April 2014 in The Indonesian Biomedical Journal
Verified
Journal Article
Open access
PDF file
FSFerry Sandra
Ferry Sandra
JSJanti Sudiono
Janti Sudiono
ESElina Ardiani Sidharta
Elina Ardiani Sidharta
ESElisabeth Pricilia Sunata
Elisabeth Pricilia Sunata
DSDea Jane Sungkono
Dea Jane Sungkono
ACAngliana Chouw
Angliana Chouw
BACKGROUND: Secreted factors contained in conditioned media (CM) of human umbilical cord blood mesenchymal stem cells (hUCB-MSCs) known as secretome, was suspected to have important roles in regulating cells. This study was conducted to investigate the role of CM-hUCB-MSCs-derived secretome in apoptosis and growth of HeLa cells. METHODS: HeLa cells were treated with secretome in various concentrations (0, 0.2, 2 and 20%) for 24 and 48 hours. Trypan blue exclusion assay was performed to detect cell viability. Meanwhile sub-G1 apoptotic assay was performed to detect apoptotic cells. The transition of mitochondrial transmembrane potential (TMP), which occurs in the apoptotic process, was analyzed by mitochondrial membrane potential (ΔΨM) assay. Both sub-G1 and ΔΨM assays were performed using FACSCanto flow cytometer. Statistical analyses were conducted using IBM SPSS Statistics to detect significance level at p<0.05. RESULTS: Secretome significantly induced cell death starting at concentration of 0.2% within a 24-hour period (p<0.05). Secretome significantly induced cell death in concentration and time dependent manner (p<0.05). The cell death was then confirmed as apoptosis through sub-G1 analysis. Due to the underlying apoptotic mechanism, we found distinct decrease of TMP, indicating an increase in mitochondrial membrane permeability of HeLa cells. In addition, we found that HeLa cell growth was inhibited partially by secretome. CONCLUSION: Taken together, we conclude that CMhUCB-MSCs-derived secretome significantly induced apoptosis of HeLa cells in a concentration and time dependent manner through mitochondrial apoptotic pathway. The secretome might also play important role in inhibiting HeLa cell growth. KEYWORDS: umbilical cord blood, mesenchymal stem cell, secretome, apoptosis, growth, cancer

25 November 2014 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
FSFerry Sandra
Ferry Sandra
YOYudi Her Oktaviono
Yudi Her Oktaviono
MWMohammad Aris Widodo
Mohammad Aris Widodo
YDYanni Dirgantara
Yanni Dirgantara
ACAngliana Chouw
Angliana Chouw
DSDjanggan Sargowo
Djanggan Sargowo

7 January 2022 in Regenerative Engineering and Translational Medicine
Verified
Journal Article
Closed access
PDF file
ACAngliana Chouw
Angliana Chouw
GFGeofanny Facicilia
Geofanny Facicilia
CSCynthia Retna Sartika
Cynthia Retna Sartika
AFAhmad Faried
Ahmad Faried
TMTiana Milanda
Tiana Milanda

1 January 2024 in Brazilian Oral Research
Verified
Journal Article
Open access
PDF file
FSFerry Sandra
Ferry Sandra
JSJanti Sudiono
Janti Sudiono
ACAngliana Chouw
Angliana Chouw
MCMaria Celinna
Maria Celinna
NDNurrani Mustika Dewi
Nurrani Mustika Dewi
MDMelanie Sadono Djamil
Melanie Sadono Djamil
Dental pulp stem cells (DPSCs) and periodontal ligament stem cells (PDLSCs) can differentiate into osteoblasts, indicating that both are potential candidates for bone tissue engineering. Osteogenesis is influenced by many environmental factors, one of which is lipopolysaccharide (LPS). LPS-induced NF-κB activity affects the osteogenic potencies of different types of MSCs differently. This study evaluated the effect of LPS-induced NF-κB activity and its inhibition in DPSCs and PDLSCs. DPSCs and PDLSCs were cultured in an osteogenic medium, pretreated with/without NF-κB inhibitor Bay 11-7082, and treated with/without LPS. Alizarin red staining was performed to assess bone nodule formation, which was observed under an inverted light microscope. NF-κB and alkaline phosphatase (ALP) activities were measured to examine the effect of Bay 11-7082 pretreatment and LPS supplementation on osteogenic differentiation of DPSCs and PDLSCs. LPS significantly induced NF-κB activity (p = 0.000) and reduced ALP activity (p = 0.000), which inhibited bone nodule formation in DPSCs and PDLSCs. Bay 11-7082 inhibited LPS-induced NF-κB activity, and partially maintained ALP activity and osteogenic potency of LPS-supplemented DPSCs and PDLSCs. Thus, inhibition of LPS-induced NF-κB activity can maintain the osteogenic potency of DPSCs and PDLSCs.

1 September 2018 in Molecular and Cellular Biomedical Sciences
Verified
Journal Article
Open access
ACAngliana Chouw
Angliana Chouw
RTRina Triana
Rina Triana
NDNurrani Mustika Dewi
Nurrani Mustika Dewi
SDSiska Darmayanti
Siska Darmayanti
MRMiftakh Nur Rahman
Miftakh Nur Rahman
CSCynthia Retna Sartika
Cynthia Retna Sartika
Stroke is a leading cause of death and long-term disability. This due to the ischemic event that cause by embolism of blockage blood flow. Thrombolytic agent plasminogen activator (tPA) is the only treatment approved by FDA. However, the used of tPA is limited to the short time window period. Neural stem cells (NSCs) show the potential to repair neuronal damage naturally after stroke. However, isolating NSCs is a challenging process due to the limitations of the method and its invasiveness. Some studies that had used mesenchymal stem cell (MSCs) as the main source of stem cell for therapy show that MSCs have the potency to differentiate into NSCs. in vitro, a differentiation process from MSC to NSC has been developed by combining the supplement or growth factor needed in the culture media.Keywords: stem cells, neuron stem cell, mesenchymal stem cell, stroke, trans-differentiation